Overview

  • Product nameAnti-PON1 antibody [17A12]
    See all PON1 primary antibodies
  • Description
    Mouse monoclonal [17A12] to PON1
  • Specificityab24261 reacts with paraoxonase1 (PON1).
  • Tested applicationsSuitable for: ICC/IF, IHC-FoFr, ELISA, WB, Flow Cytmore details
  • Species reactivity
    Reacts with: Mouse, Rat, Hamster, Human, Rhesus monkey
    Predicted to work with: Rabbit
  • Immunogen

    His tagged recombinant Human PON1 protein purified E.coli.

  • Positive control
    • HeLa, HepG2 cell lysates, mouse liver tissue lysate.

Applications

Our Abpromise guarantee covers the use of ab24261 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ICC/IF Use a concentration of 1 - 5 µg/ml.
IHC-FoFr Use at an assay dependent concentration.
ELISA Use at an assay dependent concentration.
WB 1/500. Predicted molecular weight: 40 kDa.
Flow Cyt Use 1µg for 106 cells. ab170190-Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.

Target

  • FunctionHydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation.
  • Tissue specificityPlasma, associated with HDL (at protein level). Expressed in liver, but not in heart, brain, placenta, lung, skeletal muscle, kidney or pancreas.
  • Involvement in diseaseGenetic variation in PON1 is associated with susceptibility to microvascular complications of diabetes type 5 (MVCD5) [MIM:612633]. These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Note=Homozygosity for the Leu-54 allele is strongly associated with the development of retinal disease in diabetic patients.
  • Sequence similaritiesBelongs to the paraoxonase family.
  • Post-translational
    modifications
    Glycosylated.
    The signal sequence is not cleaved.
    Present in two forms, form B contains a disulfide bond, form A does not.
  • Cellular localizationSecreted > extracellular space.
  • Information by UniProt
  • Database links
  • Alternative names
    • A esterase 1 antibody
    • A-esterase 1 antibody
    • Aromatic esterase 1 antibody
    • Arylesterase 1 antibody
    • Arylesterase B type antibody
    • ESA antibody
    • Esterase A antibody
    • K 45 antibody
    • K-45 antibody
    • MVCD5 antibody
    • Paraoxonase 1 antibody
    • Paraoxonase antibody
    • Paraoxonase B type antibody
    • Paraoxonase, plasma antibody
    • Paraoxonase1 antibody
    • PON 1 antibody
    • PON antibody
    • PON1 antibody
    • PON1_HUMAN antibody
    • Serum aryldiakylphosphatase antibody
    • Serum aryldialkylphosphatase 1 antibody
    • Serum paraoxonase/arylesterase 1 antibody
    see all

Anti-PON1 antibody [17A12] images

  • All lanes : Anti-PON1 antibody [17A12] (ab24261) at 1/500 dilution

    Lane 1 : HeLa cell lysates.
    Lane 2 : HepG2 cell lysates.


    Predicted band size : 40 kDa
  • ab24261 (1µg/ml) staining PON1 in human liver using an automated system (DAKO Autostainer Plus). Using this protocol there is strong cytoplasmic staining of hepatocytes.
    Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer citrate pH 6.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.
  • Overlay histogram showing HepG2 cells stained with ab24261 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab24261, 1µg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 100% methanol (5 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.

  • ICC/IF image of ab24261 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab24261, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  • Anti-PON1 antibody [17A12] (ab24261) at 1/500 dilution + Recombinant Human PON1 protein (ab53376) at 0.01 µg

    Secondary
    Goat Anti-Mouse IgG H&L (HRP) preadsorbed (ab97040) at 1/500 dilution
    Developed using the ECL technique

    Performed under reducing conditions.

    Exposure time : 1 minute

References for Anti-PON1 antibody [17A12] (ab24261)

This product has been referenced in:
  • Pei JF  et al. Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice. Sci China Life Sci 59:1115-1122 (2016). Read more (PubMed: 27578362) »
  • Stancu CS  et al. Probiotics determine hypolipidemic and antioxidant effects in hyperlipidemic hamsters. Mol Nutr Food Res 58:559-68 (2014). WB ; Hamster . Read more (PubMed: 24105997) »

See all 10 Publications for this product

Product Wall

Application Western blot
Sample Hamster Tissue lysate - whole (Hamster (Mesocricetus auratus) liver)
Gel Running Conditions Reduced Denaturing (10% SDS-PAGE)
Loading amount 60 µg
Treatment Western diet (N normal, HL hyperlipemic), 16 weeks
Specification Hamster (Mesocricetus auratus) liver
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 22°C
Username

Dr. Anca Sima

Verified customer

Submitted May 21 2015

Thank you for contacting us.

I can confirm that antibody ab24261 can be used in ELISA (Indirect) with human cell lysates/ proteins.

I hope this information is helpful to you. Please do not hesitate to contact us if you need any more a...

Read More

Thank you for your phone call yesterday, and I apologize that we did not already have this information. I have heard back from the lab, and the buffer of ab24261 contains 10 mM HEPES. I hope this information is helpful, but please let me know if ...

Read More

Sorry for the long wait. I have another update about one of the products you previously enquired. ab26930: We have not tested this product for cross reactivity with PON2 and PON3. ab24261: There is no reply from the originator and I would as...

Read More

I'm sorry to hear you are experiencing poor results with ab24261 in western blotting. Your protocol seems good in general and I have only a few suggestions which I help with resolve the problem: -As you are using a good positive control of HeLa c...

Read More

Thank you for your enquiry. This product has been raised against the full length recombinant form of the target. I hope that this information helps.

Thank you for your enquiry. The antibody ab2461 has been tested in human samples of HeLa cell lysate and HepG2 cell lysate and in mouse samples on mouse liver tissue lysate on different gels therefore we cannot compare the amount of PON1 protein dete...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"